Aratana Therapeutics Inc (NASDAQ:PETX)

19.26
Delayed Data
As of Feb 27
 +0.03 / +0.16%
Today’s Change
9.20
Today|||52-Week Range
23.82
+8.08%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Aratana Therapeutics Inc have a median target of 26.00, with a high estimate of 38.00 and a low estimate of 21.50. The median estimate represents a +34.99% increase from the last price of 19.26.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Aratana Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.35
Sales
$110.4K
Reporting Date
Mar 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.82%
 
 
 
 
 
 
Growthannually -251.92%
 
 
 
 

Sales

Growthquarterly 156.72%
 
 
 
 
 
 
Growthannually 408.92%
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account